SCM
BIIB icon

Sterling Capital Management’s Biogen BIIB Stock Holding History

Sterling Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
4,810
-326
-6% -$62.4K 0.02% 536
2026
Q1 		$942K Sell
5,136
-3,525
-41% -$650K 0.02% 525
2025
Q4 		$1.52M Sell
8,661
-371
-4% -$60.6K 0.02% 492
2025
Q3 		$1.27M Sell
9,032
-691
-7% -$93.4K 0.02% 560
2025
Q2 		$1.22M Buy
9,723
+1,622
+20% +$202K 0.02% 557
2025
Q1 		$1.11M Sell
8,101
-535
-6% -$76.5K 0.02% 581
2024
Q4 		$1.32M Buy
8,636
+3,071
+55% +$518K 0.02% 553
2024
Q3 		$1.08M Buy
+5,565
New +$1.16M 0.01% 571
2019
Q3 		$3.53M Sell
15,166
-20,800
-58% -$4.84M 0.03% 295
2019
Q2 		$8.41M Buy
35,966
+11,763
+49% +$2.72M 0.08% 197
2019
Q1 		$5.72M Sell
24,203
-685
-3% -$216K 0.06% 230
2018
Q4 		$7.49M Buy
24,888
+180
+0.7% +$57.4K 0.08% 196
2018
Q3 		$8.73M Buy
+24,708
New +$8.51M 0.08% 206
2018
Q2 		– Sell
-28,718
Closed -$7.86M – 845
2018
Q1 		$7.86M Buy
28,718
+3,330
+13% +$1.03M 0.07% 211
2017
Q4 		$8.09M Buy
25,388
+15,560
+158% +$4.99M 0.07% 214
2017
Q3 		$3.08M Buy
9,828
+8,707
+777% +$2.58M 0.03% 307
2017
Q2 		$304K Sell
1,121
-26,196
-96% -$6.93M ﹤0.01% 833
2017
Q1 		$7.47M Buy
+27,317
New +$7.72M 0.07% 210
2015
Q3 		– Sell
-530
Closed -$214K – 969
2015
Q2 		$214K Buy
+530
New +$213K ﹤0.01% 846
2014
Q3 		– Sell
-1,403
Closed -$442K – 893
2014
Q2 		$442K Buy
+1,403
New +$422K ﹤0.01% 753
2014
Q1 		– Sell
-840
Closed -$235K – 937
2013
Q4 		$235K Sell
840
-14,746
-95% -$3.81M ﹤0.01% 755
2013
Q3 		$3.75M Buy
+15,586
New +$3.49M 0.04% 165

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sterling Capital Management's BIIB Position: Q2 2026 in Review

Sterling Capital Management reduced its Biogen (BIIB) stake by 6.3% in Q2 2026, selling an estimated $62.4K and leaving 4,810 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #536.

Sterling Capital Management first reported a position in BIIB in Q3 2013 and has held it in 22 quarters since. The position peaked at $8.73M in Q3 2018. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Sterling Capital Management held 4,810 shares of Biogen worth $1.04M as of Q2 2026.
  • Sterling Capital Management sold 326 Biogen shares in Q2 2026, an estimated $62.4K.
  • Biogen made up 0.02% of Sterling Capital Management's portfolio in Q2 2026, its #536 holding.
  • Sterling Capital Management first reported a position in Biogen in Q3 2013 and has held it in 22 quarters since.
  • Sterling Capital Management's Biogen position peaked at $8.73M in Q3 2018.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.